Related Experiment Videos
Stress-related mucosal damage: critical evaluation of potential new therapeutic agents
1Division of Gastroenterology, University of Maryland Hospital, Baltimore 21201.
Abstract:
Cell injury produced by hydrochloric acid is the final common denominator for stress-related mucosal damage. Actions of therapeutic agents designed to prevent such damage are directed toward either inhibiting acid secretion or stimulating protective mechanisms. Newer agents that fall into the former category include omeprazole, an inhibitor of the H+-K+-ATPase pump, prostaglandins, and somatostatin. In addition to inhibiting acid, prostaglandins stimulate mucus and bicarbonate secretion and therefore provide a two-pronged protective action. Tranexamic acid is an antifibrinolytic agent that is postulated to promote clotting at bleeding sites in upper gastrointestinal lesions. Analyses of composite data suggest that (1) prostaglandin E preparations appear to be as effective as currently recognized forms of therapy, such as antacid and H2-receptor antagonist administration; (2) little enthusiasm can currently be generated for use of somatostatin or tranexamic acid; and (3) omeprazole is a theoretically attractive agent that remains to be tested in the prophylactic treatment of gastrointestinal ulceration due to severe stress.
Insights
Newer agents like prostaglandins show promise in preventing stress-related mucosal damage by inhibiting acid and boosting protective mucus. Omeprazole is a potential future therapy for gastrointestinal ulcers.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Hydrochloric acid-induced cell injury is central to stress-related mucosal damage.
- Therapeutic strategies focus on inhibiting acid secretion or enhancing mucosal defenses.
Purpose of the Study:
- To evaluate newer agents for preventing stress-related mucosal damage.
- To assess the efficacy of prostaglandins, somatostatin, tranexamic acid, and omeprazole.
Main Methods:
- Analysis of composite data from studies on therapeutic agents.
- Comparison of newer agents against established therapies like antacids and H2-receptor antagonists.
Main Results:
- Prostaglandin E preparations demonstrate efficacy comparable to current standard therapies.
- Somatostatin and tranexamic acid show limited current therapeutic potential.
- Omeprazole, a proton pump inhibitor, is a promising candidate for future testing.
Conclusions:
- Prostaglandins offer a dual protective mechanism against mucosal damage.
- Further research is needed to establish omeprazole's role in preventing stress-induced gastrointestinal ulceration.